Can a blood injection strengthen pelvic tissue after prolapse repair?
NCT ID NCT07150442
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study tests whether injecting platelet-rich plasma (PRP) into the vaginal tissue during pelvic organ prolapse surgery improves healing. Thirty postmenopausal women with moderate-to-severe prolapse will receive either PRP or a placebo injection during surgery. Researchers will measure collagen ratios and other tissue markers before and 8 weeks after surgery to see if PRP helps strengthen the pelvic floor.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Platelet-rich plasma (PRP) injection
- What this could lead to
- If it works, this could show that adding PRP to prolapse surgery improves tissue strength and reduces the chance of prolapse returning.
- What could go wrong
- This is a very small, early study (30 people) looking at tissue markers, not long-term outcomes. PRP may not provide any benefit over surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
34 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients with second-degree or higher pelvic organ prolapse 2. Postmenopausal pelvic organ prolapse patients 3. Patients with pelvic organ prolapse who will undergo surgery 4. Willingness to participate in the study Exclusion Criteria: 1. Patients with gynecological malignancies 2. Patients with a history of collagen disease 3. Patients with blood disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse vaginal surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Biomedical Science Doctoral Programme Faculty of Medicine Andalas University/ Urogynecology Division Obstetrics and Gynecology Department M Djamil Hospital Padang
Padang, West Sumatera, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple stitch reduce repeat prolapse surgery?
- Can a Blood-Derived injection strengthen pelvic floor repair?
- Large study to track bladder leaks after prolapse surgery in over 1,000 women
- Major trial to settle best surgery for womb prolapse
- Which PRP machine works best for knee arthritis? small study aims to find out
- Knee pain relief showdown: PRP vs. Cytokine-Rich serum